Biochemistry, Genetics and Molecular Biology
Genetics
100%
Clinical Trial
66%
Event Free Survival
66%
DUX4
66%
MEF2D
66%
Flow Cytometry
33%
Overall Survival
33%
Survival Rate
33%
RNA Sequence
33%
Multiplex Ligation-Dependent Probe Amplification
33%
ETV6
33%
RUNX1
33%
KMT2A
33%
Dasatinib
33%
T Cell
33%
Immunology and Microbiology
Event Free Survival
100%
RNA Sequence
50%
Overall Survival
50%
Survival Rate
50%
Multiplex Ligation Dependent Probe Amplification
50%
T Cell
50%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Minimal Residual Disease
100%
Clinical Trial
16%
Event Free Survival
16%
Survival Rate
8%
Neoplasm
8%
RNA Sequence
8%
Flow Cytometry
8%
Overall Survival
8%
Pediatrics
8%
Spontaneous Remission
8%
Childhood Cancer
8%
Multiplex Ligation Dependent Probe Amplification
8%
Dasatinib
8%